Best Healthcare Companies in King Of Prussia, United States
The 33 best Healthcare companies in King Of Prussia, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Center for Breakthrough Medicines.
Ranked: Best Healthcare companies in King Of Prussia
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Center for Breakthrough Medicines Provider of process & analytical development and research services | $350M | 57 mo ago | Acquired | — | 2015 | — | — | — |
| 2 | Recovery Centers of America Chain of inpatient & outpatient substance abuse rehabilitation centers | $332M | 119 mo ago | Late Stage | — | 2014 | WordPressMySQLPHP+29 | — | — |
| 3 | Aspire Bariatrics Standalone multispecialty clinic | $12M | 216 mo ago | Series C | Katherine Crothall CEO & President | 2005 | — | 79 patents Gastric drainage devices and skin-port connectors for bariatric surgery applications. | — |
| 4 | Tavanta Developer of drug for debilitating multiple medical conditions | $4M | 177 mo ago | Seed | Lynne Powell CEO | 2011 | — | — | — |
| 5 | Emergent Medical Foods Manufacturer of nutritional supplements | $100K | 75 mo ago | Seed | John V. Cappello CEO | 2019 | — | — | — |
| 6 | Universal Health Services Provider of healthcare management services with a network of acute care and behavioral health facilities | — | 38 mo ago | Acquired | Alan Miller Founder and Executive Chairman | 1979 | Apple iCloud MailTypeScriptJava+27 | — | — |
| 7 | CSL Behring Developer of therapeutic solutions for the treatment of coagulation disorder | — | 76 mo ago | Funding Raised | — | 2009 | SitecoreApple iCloud MailMicrosoft ASP.NET+15 | 228 patents Viral vector design, purification, and delivery systems for gene therapy and biologic therapeutics | — |
| 8 | ImageFIRST Provider of linen & laundry services for hospitals | — | 96 mo ago | Acquired | — | 1967 | WordPress Block EditorWordPressMySQL+28 | — | — |
Top 9 Healthcare companies in King Of Prussia
#1
Acquired · King Of Prussia, Pennsylvania · founded 2015 · 311 employees$350Mraised▾
Provider of process & analytical development and research services
- Jan 2022Series D$350M
#2
Late Stage · King Of Prussia, Pennsylvania · founded 2014 · 460 employees$331.5Mraised▾
Chain of inpatient & outpatient substance abuse rehabilitation centers
- Nov 2016PE$100M
- Dec 2015PE$231.5M
#3
Series C · King Of Prussia, Pennsylvania · founded 2005$12.5Mraised▾
Standalone multispecialty clinic
- Oct 2008Series C$12.5M
- Series B—
#4
Seed · King Of Prussia, Pennsylvania · founded 2011 · 12 employees$4.1Mraised▾
Tavanta develops a drug for debilitating multiple medical conditions. It is a clinical-stage pharmaceutical company involve in the development of a diverse drug pipeline. The company is in phase 3 for drug candidate TAVT-45 targeting Prostate Cancer, phase 2 for TAVT-119 (Chronic Anal Fissures), TAVT-124 is in the early stage of phase 2 for Multiple Sclerosis, and in phase 1 for TAVT-124 and TAVT-135; for Autoimmune Indications and Cystic Fibrosis. The company uses an HT Matrix screening platform for the development of peptide conjugate development.
- Jan 2012Seed$4.1M
#5
Seed · King Of Prussia, Pennsylvania · founded 2019$100Kraised▾
Manufacturer of nutritional supplements
#6
Acquired · King Of Prussia, Pennsylvania · founded 1979 · 51 employees—raised▾
Provider of healthcare management services with a network of acute care and behavioral health facilities. It is a provider of health care technology management and service solutions to the health care industry. The facility also offers healthcare management and consulting, physician management and health insurance services.
#7
Funding Raised · King Of Prussia, Pennsylvania · founded 2009 · 9234 employees—raised▾
CSL Behring is focused on the development, manufacture, and marketing of protein-based therapies for serious and chronic medical conditions. The company offers products in the area of Bleeding Disorders Therapies, Fluid Replacement Therapies, Hereditary Angioedema (HAE) Therapies, Immunoglobulin Therapies, Pulmonary Therapies, and Wound Healing Therapies. The products are used for the treatment of coagulation disorders including von Willebrand disease (VWD), hemophilia, primary immunodeficiency (PID), hereditary Angioedema (HAE), fibrinogen deficiency, genetic emphysema, and other rare diseases.
- Jun 2020Grant (prize money)—
#8
Acquired · King Of Prussia, Pennsylvania · founded 1967 · 2913 employees—raised▾
Provider of linen & laundry services for hospitals
#9
Series A · King Of Prussia, Pennsylvania · founded 2002—raised▾
IsoSciences, part of the MPD Holdings group of companies, is engaged in the development and manufacturing of stable isotope labeled materials of advanced intermediates, reference compounds, metabolites, and final drugs substances for the diagnostic, nutritional, and pharmaceutical industries. Since inception, the company has developed 1000+ products for the clinical diagnostics and pharmaceutical markets. Their clientele ranges from Fortune 500 pharmaceutical companies to small research universities. The company's custom synthesized stable isotope labeled APIs and metabolites find applications in LC/MS/MS studies. Their final products are accompanied with a CoA which includes HPLC purity, isotope incorporation and structural identity by 1H and 13C-NMR. The company is ISO 9001 certified also has capabilities to offer stable isotope labeled steroids and vitamins. IsoSciences has expertise in 2H, 13C and 15N labeling techniques for heterocyclic, steroid, sugar, vitamin, and natural products.
- Dec 2011Series A—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.